Aidan Quinn Innes

Aidan Quinn Innes

Auto-generated profile, based on publicly available information

Aidan Quinn Innes

Nuffield Health Research Group, Nuffield Health, Ashley Avenue, Epsom, Surrey, KT18 5AL, UK

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2021 in Computers in Biology and Medicine
Verified
Journal Article
Open access
ZLZhifang Liao
Zhifang Liao
PLPeng Lan
Peng Lan
Xiaoping FanXiaoping Fan
Xiaoping Fan
BKBenjamin Kelly
Benjamin Kelly
AIAidan Innes
Aidan Innes
ZLZhining Liao
Zhining Liao
COVID-19 is one of the biggest challenges that human beings have faced recently. Many researchers have proposed different prediction methods for establishing a virus transmission model and predicting the trend of COVID-19. Among them, the methods based on artificial intelligence are currently the most interesting and widely used. However, only using artificial intelligence methods for prediction cannot capture the time change pattern of the transmission of infectious diseases. To solve this problem, this paper proposes a COVID-19 prediction model based on time-dependent SIRVD by using deep learning. This model combines deep learning technology with the mathematical model of infectious diseases, and forecasts the parameters in the mathematical model of infectious diseases by fusing deep learning models such as LSTM and other time prediction methods. In the current situation of mass vaccination, we analyzed COVID-19 data from January 15, 2021, to May 27, 2021 in seven countries – India, Argentina, Brazil, South Korea, Russia, the United Kingdom, France, Germany, and Italy. The experimental results show that the prediction model not only has a 50% improvement in single-day predictions compared to pure deep learning methods, but also can be adapted to short- and medium-term predictions, which makes the overall prediction more interpretable and robust.

24 May 2023 in Frontiers in Medicine
Verified
Journal Article
Open access
JSJemma L. Smith
Jemma L. Smith
KDKevin Deighton
Kevin Deighton
AIAidan Q. Innes
Aidan Q. Innes
MHMarc Holl
Marc Holl
LMLaura Mould
Laura Mould
BKBenjamin M. Kelly
Benjamin M. Kelly
Introduction: Two million people in the UK are experiencing long COVID (LC), which necessitates effective and scalable interventions to manage this condition. This study provides the first results from a scalable rehabilitation programme for participants presenting with LC.Methods: 601 adult participants with symptoms of LC completed the Nuffield Health COVID-19 Rehabilitation Programme between February 2021 and March 2022 and provided written informed consent for the inclusion of outcomes data in external publications. The 12-week programme included three exercise sessions per week consisting of aerobic and strength-based exercises, and stability and mobility activities. The first 6 weeks of the programme were conducted remotely, whereas the second 6 weeks incorporated face-to-face rehabilitation sessions in a community setting. A weekly telephone call with a rehabilitation specialist was also provided to support queries and advise on exercise selection, symptom management and emotional wellbeing.Results: The 12-week rehabilitation programme significantly improved Dyspnea-12 (D-12), Duke Activity Status Index (DASI), World Health Orginaisation-5 (WHO-5) and EQ-5D-5L utility scores (all p < 0.001), with the 95% confidence intervals (CI) for the improvement in each of these outcomes exceeding the minimum clinically important difference (MCID) for each measure (mean change [CI]: D-12: −3.4 [−3.9, −2.9]; DASI: 9.2 [8.2, 10.1]; WHO-5: 20.3 [18.6, 22.0]; EQ-5D-5L utility: 0.11 [0.10, 0.13]). Significant improvements exceeding the MCID were also observed for sit-to-stand test results (4.1 [3.5, 4.6]). On completion of the rehabilitation programme, participants also reported significantly fewer GP consultations (p < 0.001), sick days (p = 0.003) and outpatient visits (p = 0.007) during the previous 3 months compared with baseline.Discussion: The blended and community design of this rehabilitation model makes it scalable and meets the urgent need for an effective intervention to support patients experiencing LC. This rehabilitation model is well placed to support the NHS (and other healthcare systems worldwide) in its aim of controlling the impacts of COVID-19 and delivering on its long-term plan.Clinical trial registration: https://www.isrctn.com/ISRCTN14707226, identifier 14707226.

23 December 2019 in BMC Public Health
Verified
Journal Article
Open access
PDF file
AIAidan Q. Innes
Aidan Q. Innes
GTGreig Thomson
Greig Thomson
MCMary Cotter
Mary Cotter
James KingJames King
James King
NVNiels B. J. Vollaard
Niels B. J. Vollaard
BKBenjamin M. Kelly
Benjamin M. Kelly
Background: Finding effective intervention strategies to combat rising obesity levels could significantly reduce the burden that obesity and associated non-communicable diseases places on both individuals and the National Health Service.Methods: In this parallel randomised-controlled trial, 76 participants who are overweight or obese (50 female) were given free access to a fitness centre for the duration of the 12-week intervention and randomised to one of three interventions. The commercial intervention, the Healthy Weight Programme, (HWP,n = 25, 10/15 men/women) consisted of twelve 1-h nutrition coaching sessions with a nutritionist delivered as a mixture of group and 1 to 1 sessions. In addition, twice-weekly exercise sessions (24 in total) were delivered by personal trainers for 12 weeks. TheNHSintervention (n = 25, 8/17 men/women) consisted of following an entirely self-managed 12-week online NHS resource. TheGYMintervention (n = 26, 8/18 men/women) received no guidance or formal intervention. All participants were provided with a gym induction for safety and both the NHS and GYM participants were familiarised with ACSM physical activity guidelines by way of a hand-out.Results: The overall follow-up rate was 83%. Body mass was significantly reduced at post-intervention in all groups (HWP:N = 18, − 5.17 ± 4.22 kg, NHS:N = 21–4.19 ± 5.49 kg; GYM:N = 24–1.17 ± 3.00 kg;p < 0.001) with greater reductions observed in HWP and NHS groups compared to GYM (p < 0.05). Out with body mass and BMI, there were no additional statistically significant time x intervention interaction effects.Conclusions: This is the first study to evaluate the efficacy of both a free online NHS self-help weight-loss tool and a commercial weight loss programme that provides face-to-face nutritional support and supervised exercise. The findings suggest that both interventions are superior to an active control condition with regard to eliciting short-term weight-loss.Trial registration: ISRCTN Registry -ISRCTN31489026. Prospectively registered: 27/07/16.

12 April 2024 in Trials
Verified
Journal Article
Open access
PDF file
EMEmma McNaught
Emma McNaught
SRSophie Reale
Sophie Reale
LBLiam Bourke
Liam Bourke
JBJanet E. Brown
Janet E. Brown
MCMichelle Collinson
Michelle Collinson
OCon behalf of the STAMINA co-investigators
on behalf of the STAMINA co-investigators
Background: UK national clinical guidance recommends that men with prostate cancer on androgen deprivation therapy are offered twice weekly supervised aerobic and resistance exercise to address iatrogenic harm caused by treatment. Very few NHS trusts have established adequate provision of such services. Furthermore, interventions fail to demonstrate sustained behaviour change. The STAMINA lifestyle intervention offers a system-level change to clinical care delivery addressing barriers to long-term behaviour change and implementation of new prostate cancer care pathways. This trial aims to establish whether STAMINA is clinically and cost-effective in improving cancer-specific quality of life and/or reducing fatigue compared to optimised usual care. The process evaluation aims to inform the interpretation of results and, if the intervention is shown to benefit patients, to inform the implementation of the intervention into the NHS. Methods: Men with prostate cancer on androgen deprivation therapy (n = 697) will be identified from a minimum of 12 UK NHS trusts to participate in a multi-centre, two-arm, individually randomised controlled trial. Consenting men will have a ‘safety to exercise’ check and be randomly allocated (5:4) to the STAMINA lifestyle intervention (n = 384) or optimised usual care (n = 313). Outcomes will be collected at baseline, 3-, 6- and 12-month post-randomisation. The two primary outcomes are cancer-specific quality of life and fatigue. The parallel process evaluation will follow a mixed-methods approach to explore recruitment and aspects of the intervention including, reach, fidelity, acceptability, and implementation. An economic evaluation will estimate the cost-effectiveness of the STAMINA lifestyle intervention versus optimised usual care and a discrete choice experiment will explore patient preferences. Discussion: The STAMINA lifestyle intervention has the potential to improve quality of life and reduce fatigue in men on androgen deprivation therapy for prostate cancer. Embedding supervised exercise into prostate cancer care may also support long-term positive behaviour change and reduce adverse events caused by treatment. Findings will inform future clinical care and could provide a blueprint for the integration of supervised exercise and behavioural support into other cancer and/or clinical services. Trial registration: ISRCTN 46385239, registered on 30/07/2020. Cancer Research UK 17002, retrospectively registered on 24/08/2022.

16 December 2019 in Research Square
Verified
Preprint
Open access
AIAidan Quinn Innes
Aidan Quinn Innes
GTGreig Thomson
Greig Thomson
MCMary Cotter
Mary Cotter
JKJames A King
James A King
NVNiels Bj Vollaard
Niels Bj Vollaard
BKBenjamin M Kelly
Benjamin M Kelly
Background Finding effective intervention strategies to combat rising obesity levels could significantly reduce the burden that obesity and associated non-communicable diseases places on both individuals and the National Health Service.Methods In this parallel randomised-controlled trial, 76 participants who are overweight or obese (50 female) were given free access to a fitness centre for the duration of the 12-week intervention and randomised to one of three interventions. The commercial intervention, the Healthy Weight Programme, (HWP, n=25, 10/15 men/women) consisted of twelve 1-hour nutrition coaching sessions with a nutritionist delivered as a mixture of group and 1 to 1 sessions. In addition, twice-weekly exercise sessions (24 in total) were delivered by personal trainers for 12 weeks. The NHS intervention (n=25, 8/17 men/women) consisted of following an entirely self-managed 12-week online NHS resource. The GYM intervention (n=26, 8/18 men/women) received no guidance or formal intervention. All participants were provided with a gym induction for safety and both the NHS and GYM participants were familiarised with ACSM physical activity guidelines by way of a hand-out. Results The overall follow-up rate was 83%. Body mass was significantly reduced at post-intervention in all groups (HWP: N=18, -5.17±4.22 kg, NHS: N=21 -4.19±5.49 kg; GYM: N=24 -1.17±3.00 kg; p < 0.001) with greater reductions observed in HWP and NHS groups compared to GYM (p<0.05). Out with body mass and BMI, there were no additional statistically significant time x intervention interaction effectsConclusions This is the first study to evaluate the efficacy of both a free online NHS self-help weight-loss tool and a commercial weight loss programme that provides face-to-face nutritional support and supervised exercise. The findings suggest that both interventions are superior to an active control condition with regard to eliciting short-term weight-loss. Trial registration ISRCTN Registry - ISRCTN31489026. Prospectively registered: 27/07/16